These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 16024531

  • 1. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [Abstract] [Full Text] [Related]

  • 2. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
    Lin J, Hsiao PW, Chiu TH, Chao JI.
    Biochem Pharmacol; 2005 Sep 01; 70(5):658-67. PubMed ID: 16004971
    [Abstract] [Full Text] [Related]

  • 3. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J, O'brate A, Zelnak A, Giannakakou P.
    Cancer Res; 2004 Dec 01; 64(23):8708-14. PubMed ID: 15574781
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 5. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
    Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Jun 01; 55(6):595-601. PubMed ID: 15731917
    [Abstract] [Full Text] [Related]

  • 6. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
    Gu J, Yamamoto H, Lu X, Ngan CY, Tsujino T, Konishi K, Takemasa I, Ikeda M, Nagata H, Hashimoto S, Matsuzaki T, Sekimoto M, Takagi A, Monden M.
    Digestion; 2006 Jun 01; 74(1):19-27. PubMed ID: 16988507
    [Abstract] [Full Text] [Related]

  • 7. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr 01; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM, Huang Y, Fang G, Bhalla K.
    Cell Growth Differ; 1996 Aug 01; 7(8):1087-94. PubMed ID: 8853905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z, Sampath J, Fukuda S, Pelus LM.
    Cancer Res; 2005 Sep 15; 65(18):8224-32. PubMed ID: 16166298
    [Abstract] [Full Text] [Related]

  • 12. [Mechanism of taxol-induced apoptosis in human breast cancer cells].
    Chen L, Zheng S, Willingham MC.
    Zhonghua Zhong Liu Za Zhi; 1997 Mar 15; 19(2):103-6. PubMed ID: 10743071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH.
    J Surg Res; 2007 Sep 15; 142(1):184-94. PubMed ID: 17603079
    [Abstract] [Full Text] [Related]

  • 15. The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
    Strauss SJ, Higginbottom K, Jüliger S, Maharaj L, Allen P, Schenkein D, Lister TA, Joel SP.
    Cancer Res; 2007 Mar 15; 67(6):2783-90. PubMed ID: 17363600
    [Abstract] [Full Text] [Related]

  • 16. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
    Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC.
    Cancer Res; 2003 Jan 01; 63(1):230-5. PubMed ID: 12517802
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 01; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460.
    Shyu KG, Huang ST, Kuo HS, Cheng WP, Lin YL.
    Acta Pharmacol Sin; 2007 Apr 01; 28(4):559-66. PubMed ID: 17376296
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cells.
    Ngan CY, Yamamoto H, Takagi A, Fujie Y, Takemasa I, Ikeda M, Takahashi-Yanaga F, Sasaguri T, Sekimoto M, Matsuura N, Monden M.
    Cancer Sci; 2008 Jan 01; 99(1):129-39. PubMed ID: 17949450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.